ABSTRACT Introduction: Atrial fibrillation is one of the common complications of mitral valve disease. Currently, in the absence of freezing equipment, it’s still impossible to fully conduct a minimally invasive Cox-maze IV procedure to treat atrial fibrillation. Methods: We analyzed the clinical data of 28 patients who underwent thoracoscopic minimally invasive mitral valve full maze surgery in our hospital from October 2021 to September 2022; 13 patients were male and 15 were female, three suffered from paroxysmal atrial fibrillation, and 25 suffered from permanent atrial fibrillation; average age was 61.88±8.30 years, and mean preoperative left atrial diameter was 47.12±8.34 mm. Isolation of left atrial posterior wall (box lesion) was completed in all patients by cut-and-sew technique and bipolar clamp ablation. Results: For these subjects, the median cardiopulmonary bypass time was 169 (109.75-202.75) minutes, aortic cross-clamping time was 106 (77.75-125.50) minutes, and ventilator assistance time was 6.5 (0-10) hours. Among them, eight subjects had the endotracheal tubes removed immediately after surgical operation. Three subjects were in the blanking period; two subjects still had atrial fibrillation at three months after operation, one of whom resumed sinus rhythm after electrical cardioversion therapy; and all the remaining 23 subjects had sinus rhythm. Conclusion: The minimally invasive cut-and-sew technique for electrical isolation of left pulmonary veins can improve sinus conversion rate of patients suffering from both mitral valve disease and atrial fibrillation. In selected subjects, it is safe and has good results in the short-term postoperative period. Introduction Currently equipment its s Coxmaze Cox Methods 2 202 2022 1 female 6188830 61 88 8 30 61.88±8.3 years 4712834 47 12 34 47.12±8.3 mm box lesion cutandsew cut sew ablation Results 16 109.75202.75 1097520275 109.75 202.75 109 75 (109.75-202.75 minutes crossclamping cross clamping 10 77.75125.50 777512550 77.75 125.50 77 125 50 (77.75-125.50 65 6 5 6. 010 0 (0-10 hours them operation period therapy Conclusion shortterm short term 20 618883 3 61.88±8. 471283 4 47.12±8. 75202 109.75202.7 109752027 10975 109.7 20275 202.7 7 (109.75-202.7 75125 77.75125.5 77751255 7775 77.7 12550 125.5 (77.75-125.5 01 (0-1 61888 61.88±8 47128 47.12±8 7520 109.75202. 10975202 1097 109. 2027 202. (109.75-202. 7512 77.75125. 7775125 777 77. 1255 125. (77.75-125. (0- 6188 61.88± 4712 47.12± 752 109.75202 1097520 (109.75-202 751 77.75125 777512 (77.75-125 (0 618 61.88 471 47.12 109.7520 109752 (109.75-20 77.7512 77751 (77.75-12 ( 61.8 47.1 109.752 (109.75-2 77.751 (77.75-1 61. 47. (109.75- (77.75- (109.75 (77.75 (109.7 (77.7 (109. (77. (109 (77 (10 (7 (1

ABSTRACT BACKGROUND: Osteoporosis, characterized by decreased bone density and increased fracture risk, imposes significant physical, psychosocial, and financial burdens. Early detection and prevention are crucial for managing osteoporosis and reducing the risk of fractures. OBJECTIVES: To investigate the relationship between Hepatitis A seropositivity and bone mineral density (BMD) in adolescents and adults and to explore the potential link between Hepatitis A infection and osteoporosis risk. DESIGN AND SETTING: This cross-sectional study used data from the National Health and Nutrition Examination Survey (NHANES) from 2011 to 2018 to evaluate the association between hepatitis A seropositivity and BMD in 15,693 participants. METHODS: Multivariable regression analysis was used to calculate the mean BMD and standard error for adolescents and adults, followed by an independent z-test to determine whether there was a significant difference between the seropositive and seronegative groups. RESULTS: Hepatitis A seropositive adolescents and adults had lower BMD than their seronegative counterparts, with significant differences in lumber spine (mean difference = -0.03 g/cm2, P < 0.01 for both age groups) and pelvis BMDs (mean difference = -0.02 g/cm2, P < 0.01 for the adult age groups), after adjusting for various covariates. CONCLUSIONS: This study confirmed that both adolescent and adult individuals seropositive for Hepatitis A antibodies had reduced BMD among both adolescents and adults, especially in the adult group. This finding suggests a possible link between Hepatitis A infection and risk of osteoporosis. BACKGROUND Osteoporosis physical psychosocial burdens fractures OBJECTIVES (BMD SETTING crosssectional cross sectional NHANES (NHANES 201 15693 15 693 15,69 participants METHODS ztest z test groups RESULTS counterparts 0.03 003 0 03 -0.0 gcm2 gcm g cm2 cm g/cm2 001 01 0.0 0.02 002 02 groups, , covariates CONCLUSIONS group 20 1569 1 69 15,6 00 -0. g/cm 0. 2 156 6 15, -0 -

ABSTRACT Introduction: Minimally invasive coronary artery bypass grafting (MICS CABG) offers a new paradigm in coronary revascularization. This study aims to compare the outcomes of MICS CABG with those of conventional median sternotomy CABG (MS CABG) within a growing minimally invasive cardiac surgical program in Singapore. Methods: Propensity matching produced 111 patient pairs who underwent MICS CABG or MS CABG between January 2009 and February 2020 at the National University Heart Centre, Singapore. Minimally invasive direct coronary artery bypass surgery patients were matched to single- or double-graft MS CABG patients (Group 1). Multivessel MICS CABG patients were matched to MS CABG patients with equal number of grafts (Group 2). Results: Overall, MICS CABG patients experienced shorter postoperative length of stay (P<0.071). In Group 2, procedural duration (P<0.001) was longer among MICS CABG patients, but it did not translate to adverse postoperative events. Postoperative outcomes, including 30-day mortality, reopening for bleeding, new onset atrial fibrillation as well as neurological, pulmonary, renal, and infectious complications were comparable between MICS and MS CABG groups. Conclusion: MICS CABG is a safe and effective approach for surgical revascularization of coronary artery disease and trends toward a reduction in hospital stay. Introduction Singapore Methods 11 200 202 Centre single doublegraft double graft 1. 1 . 1) 2. 2 2) Results Overall P<0.071. P0071 P P<0.071 0 071 (P<0.071) P<0.001 P0001 001 (P<0.001 events 30day day 30 mortality bleeding neurological pulmonary renal groups Conclusion 20 P007 P<0.07 07 (P<0.071 P<0.00 P000 00 (P<0.00 3 P00 P<0.0 (P<0.07 (P<0.0 P0 P<0. (P<0. P<0 (P<0 P< (P< (P

ABSTRACT Division of the anterior descending branch into many small arteries is a rare coronary anomaly. We report the case of a 64-year-old female with severe stenosis (>75%) in the proximal region of the anterior descending branch as indicated by coronary computed tomography angiography (CCTA). In addition, coronary angiography showed that the anterior descending branch of the coronary artery split into numerous small arteries, an anomaly that can confound clinical examination. 64yearold yearold 64 year old >75% 75 (>75% CCTA. CCTA . (CCTA) addition examination 6 >75 7 (>75 (CCTA >7 (>7 > (> (

Abstract Background: Anemia is common in the preoperative setting and associated with increased postoperative complications and mortality. However, it is unclear if preoperative anemia optimization reduces postoperative complications. We aimed to assess the association between preoperative anemia optimization and a composite endpoint of major cardiovascular, renal, and pulmonary complications and all-cause mortality within 30 days after noncardiac surgery in adult patients. Methods: In this retrospective analysis preoperative anemia was defined as hemoglobin concentration below 12.0 g.dl−1 in women and 13.0 g.dl−1 in men within 6 months before surgery. A propensity score-based generalized estimating equation analysis was used to determine the association between preoperative anemia optimization and the primary outcome. Moreover, mediation analysis was conducted to investigate whether intraoperative red blood cell transfusion or duration of intraoperative hypotension were mediators of the relation between anemia optimization and the primary outcome. Results: Fifty-seven hundred anemia optimized, and 8721 non-optimized patients met study criteria. The proportion of patients having any component of the composite of major complications and all-cause mortality was 21.5% in the anemia-optimized versus 18.0% in the non-optimized, with confounder-adjusted odds ratio estimate of 0.99 (95% CI 0.86–1.15) for anemia optimization versus non-optimization, p = 0.90. Intraoperative red blood cell transfusion had a minor mediation effect on the relationship between preoperative anemia optimization and the primary outcome, whereas duration of intraoperative hypotension was not found to be a mediator. Conclusion: Preoperative anemia optimization did not appear to be associated with a composite outcome of major in-hospital postoperative cardiovascular, renal, and pulmonary complications and all-cause in-hospital mortality. Background However cardiovascular renal allcause all cause 3 Methods 120 12 0 12. gdl1 gdl g dl 1 g.dl− 130 13 13. scorebased score based Moreover Results Fiftyseven Fifty seven optimized 872 nonoptimized non criteria 215 21 5 21.5 anemiaoptimized 180 18 18.0 nonoptimized, confounderadjusted confounder adjusted 099 99 0.9 95% 95 (95 0.86–1.15 086115 86 15 nonoptimization, nonoptimization optimization, non-optimization 090 90 0.90 mediator Conclusion inhospital hospital g.dl 87 2 21. 18. 09 9 0. (9 0.86–1.1 08611 8 ( 0.86–1. 0861 0.86–1 086 0.86– 08 0.86 0.8

Abstract Objectives To evaluate the therapeutic effect of Saccharomyces boulardii supplementation on jaundice in premature infants undergoing phototherapy. Methods In this article, the authors reviewed 100 hospitalized jaundiced premature infants under 35 weeks of gestational age. All infants were assigned to a control group (n= 45) and a treatment group (n= 55) randomly. The infants in the treatment group received S. boulardii supplementation by undergoing phototherapy and the infants in the control group were only treated by phototherapy. The total serum bilirubin levels were detected before and at the end of phototherapy, and transcutaneous bilirubin levels were measured on the 1st, 4th, 8th and 15th day of treatment. The duration of jaundice resolution and phototherapy, stool frequency, and characteristics were compared after phototherapy. Results The duration of jaundice resolution and phototherapy were shortened. Total serum bilirubin level was lower than the control group at the end of phototherapy (p < 0.05). Transcutaneous bilirubin levels decreased more significantly on the 8th and 15th day of treatment (p < 0.05), while there were no significant differences on the post-treatment 1st and 4th day (p > 0.05). In addition, bowel movements including stool frequency and Bristol Stool Form Scale ratings of stools also improved after treatment. Conclusions S. boulardii in combination with phototherapy is effective and safe in reducing bilirubin levels and duration of phototherapy, accelerating jaundice resolution in premature infants with jaundice. The procedure also provided an ideal therapeutic effect of diarrhea induced by phototherapy to promote compliance and maternal-infant bonding. article 10 3 age n= n (n 45 55 randomly S st th shortened p 0.05. 005 0.05 . 0 05 0.05) 0.05, , posttreatment post addition maternalinfant maternal infant bonding 1 4 5 00 0.0 0.

Rapid recognition of the sources of drugs can provide some valuable clues and the basis for determining the nature of the case. A novel recognition method was put forward to identify the sources of heroin drugs rapidly and non-destructively by using a hand-held near infrared (NIR) spectrometer and a multi-layer-extreme learning machine (ML-ELM) algorithm. In contrast to traditional linear discriminant analysis (LDA), support vector machine (SVM) and extreme learning machine (ELM) algorithms, the accuracy, sensitivity and specificity were the highest for the proposed ML-ELM algorithm. The prediction accuracy of the ML-ELM algorithm was 25.33, 20.00, 17.33% higher than that of LDA, SVM and ELM algorithm, respectively, for 4 cases. The ML-ELM models for recognizing the different sources of heroin drugs had the best generalization ability and prediction results. The experimental results indicated that the combination of the hand held NIR technology and ML-ELM algorithm can recognize the different sources of heroin drugs rapidly, accurately, and non-destructively on the spot. case nondestructively non destructively handheld (NIR multilayerextreme multi layer MLELM ML (ML-ELM LDA , (LDA) (SVM (ELM algorithms 2533 25 33 25.33 2000 20 00 20.00 1733 17 17.33 respectively cases accurately spot (LDA 253 2 3 25.3 200 0 20.0 173 1 17.3 25. 20. 17.

ABSTRACT Introduction: Knockdown of fat mass and obesity-associated gene (FTO) can induce N6-methyladenosine (m 6A) ribonucleic acid (RNA) methylation. The objective of this study was to explore the effect of m 6A RNA methylation on atherosclerotic vulnerable plaque by FTO knockdown. Methods: A total of 50 New Zealand white rabbits were randomly divided into pure high-fat group, sham operation group, vulnerable plaque group, empty load group, and FTO knockdown group (10 rabbits/group). Results: Flow cytometry showed that helper T (Th) cells in the FTO knockdown group accounted for a significantly higher proportion of lymphocytes than in the vulnerable plaque group and empty load group (P<0.05). Th cells were screened by cell flow. The level of m 6A RNA methylation in the FTO knockdown group was significantly higher than in the vulnerable plaque group and empty load group (P<0.05). The levels of total cholesterol, triglyceride, and low-density lipoprotein C were higher at the 12th week than at the 1st week, but the high-density lipoprotein C level was lower at the 12th week than at the 1st week. At the 12th week, the interleukin-7 level was significantly lower in the adeno-associated virus-9 (AVV9)-FTO short hairpin RNA group than in the control and AVV9-green fluorescent protein groups (P<0.001). Conclusion: After successfully establishing a vascular parkinsonism rabbit model, m 6A RNA methylation can decrease Th cells and vulnerable atherosclerotic plaques. Introduction obesityassociated obesity associated (FTO N6methyladenosine Nmethyladenosine N6 methyladenosine N (RNA Methods 5 highfat high 10 (1 rabbits/group. rabbitsgroup rabbits/group . rabbits/group) Results (Th P<0.05. P005 P P<0.05 0 05 (P<0.05) flow cholesterol triglyceride lowdensity low density th st highdensity interleukin7 interleukin 7 interleukin- adenoassociated adeno virus9 virus 9 virus- AVV9FTO AVVFTO AVV9 AVV AVV9green AVVgreen green P<0.001. P0001 P<0.001 001 (P<0.001) Conclusion model plaques 1 ( P00 P<0.0 (P<0.05 P000 P<0.00 00 (P<0.001 P0 P<0. (P<0.0 (P<0.00 P<0 (P<0. P< (P<0 (P< (P

ABSTRACT Introduction: Remote ischemic preconditioning (RIPC) is a new noninvasive myocardial protection strategy that uses blood pressure cuf inflation to simulate transient non-fatal ischemia to protect the myocardium and reduce ischemia-reperfusion injury. Sulfonylureas may mask the effects of RIPC due to their cardioprotec-tive effect. This meta-analysis aimed to evaluate whether RIPC, in the absence of sulfonylureas, reduces troponin release in patients undergoing cardiac surgery. Methods: We conducted a meta-analysis of randomized controlled clinical trials to determine whether RIPC can reduce postoperative troponin release in cardiac surgery patients undergoing cardiopulmonary bypass without treatment with sulfonylureas. The data were normalized to equivalent units prior to the analysis. A random-effects model was used to provide more conservative estimate of the effects in the presence of known or unknown heterogeneity. Results: Six studies with a total of 570 participants were included. The analysis showed that troponin release was lower in the RIPC group than in the control group at six hours (test of standardized mean differences = 0, Z=3.64, P<0.001) and 48 hours (Z=2.72, P=0.007) postoperatively. When the mean of cross-clamping time was > 60 minutes, RIPC reduced troponin release at six hours (Z=2.84, P=0.005), 24 hours (Z=2.64, P=0.008), and 48 hours (Z=2.87, P=0.004) postoperatively. Conclusion: In cardiac surgery patients who are not taking sulfonylureas, RIPC can reduce troponin release at six and 48 hours postoperatively; hence, RIPC may serve significant benefits in certain cardiac surgery patients. Introduction (RIPC nonfatal non fatal ischemiareperfusion reperfusion injury cardioprotective cardioprotec tive effect metaanalysis meta sulfonylureas Methods randomeffects random heterogeneity Results 57 included test 0 Z364 Z 3 64 Z=3.64 P<0.001 P0001 P 001 4 Z=2.72, Z272 2 72 (Z=2.72 P=0.007 P0007 007 postoperatively crossclamping cross clamping 6 minutes Z=2.84, Z284 84 (Z=2.84 P=0.005, P0005 P=0.005 , 005 P=0.005) Z=2.64, Z264 (Z=2.64 P=0.008, P0008 P=0.008 008 P=0.008) Z=2.87, Z287 87 (Z=2.87 P=0.004 P0004 004 Conclusion hence 5 Z36 Z=3.6 P<0.00 P000 00 Z=2.72 Z27 7 (Z=2.7 P=0.00 Z=2.84 Z28 8 (Z=2.8 Z=2.64 Z26 (Z=2.6 Z=2.87 Z3 Z=3. P<0.0 P00 Z=2.7 Z2 (Z=2. P=0.0 Z=2.8 Z=2.6 Z=3 P<0. P0 Z=2. (Z=2 P=0. Z= P<0 Z=2 (Z= P=0 P< (Z P=

The mutations of breast cancer susceptibility gene 1 (BRCA1) play an important role in inherited breast cancers. Thus, the sensitive assay of the BRCA1 gene is extremely important for disease diagnosis and human health. Herein, a fast, sensitive and selective assay technique has been constructed based on fluorescent copper nanoclusters (CuNCs). The CuNCs were successfully formed with poly(AT-TA) double stranded DNA (dsDNA) as template. In the absence of the target, a strong red emission was observed under 365 nm ultraviolet (UV) lamp and a big fluorescence response was obtained. However, in the presence of BRCA1 gene, there was only weak red emission and a low response signal was produced because of the target-proximity induced quenching of the fluorescence of CuNCs. The linear range for the BRCA1 gene assay was 2-600 nM, and the limit of detection was 2 nM. The assay technique showed good selectivity, good stability and satisfactory recoveries for the detection of BRCA1 gene in diluted serum samples. Moreover, by integrating a UV lamp and a smartphone, the fluorescence sensor would be transferred to a microfluidic chip, providing a prospective application in point-of-care for monitoring breast cancer risk. BRCA (BRCA1 cancers Thus health Herein fast . (CuNCs) polyATTA poly AT TA poly(AT-TA dsDNA (dsDNA template target 36 (UV obtained However targetproximity proximity 2600 600 2-60 nM selectivity samples Moreover smartphone chip pointofcare point care risk (BRCA (CuNCs 3 260 60 2-6 26 6 2-

Abstract Background: Bungarus multicinctus is one of the most dangerous venomous snakes prone to cardiopulmonary damage with extremely high mortality. In our previous work, we found that glutamine (Gln) and glutamine synthetase (GS) in pig serum were significantly reduced after Bungarus multicinctus bite. In the present study, to explore whether there is a link between the pathogenesis of cardiopulmonary injury and Gln metabolic changes induced by Bungarus multicinctus venom. We investigated the effect of Gln supplementation on the lung and heart function after snakebite. Methods: We supplemented different concentrations of Gln to mice that were envenomated by Bungarus multicinctus to observe the biological behavior, survival rate, hematological and pathological changes. Gln was supplemented immediately or one hour after the venom injection, and then changes in Gln metabolism were analyzed. Subsequently, to further explore the protective mechanism of glutamine on tissue damage, we measured the expression of heat-shock protein70 (HSP70), NF-κB P65, P53/PUMA by western blotting and real-time polymerase in the lung and heart. Results: Gln supplementation delayed the envenoming symptoms, reduced mortality, and alleviated the histopathological changes in the heart and lung of mice bitten by Bungarus multicinctus. Additionally, Gln increased the activity of glutamine synthetase (GS), glutamate dehydrogenase (GDH) and glutaminase (GLS) in serum. It also balanced the transporter SLC7A11 expression in heart and lung tissues. Bungarus multicinctus venom induced the NF-κB nuclear translocation in the lung, while the HO-1 expression was suppressed. At the same time, venom activated the P53/PUMA signaling pathway and the BAX expression in the heart. Gln treatment reversed the above phenomenon and increased HSP70 expression. Conclusion: Gln alleviated the glutamine metabolism disorder and cardiopulmonary damage caused by Bungarus multicinctus venom. It may protect lungs and heart against venom by promoting the expression of HSP70, inhibiting the activation of NF-κB and P53/PUMA, thereby delaying the process of snake venom and reducing mortality. The present results indicate that Gln could be a potential treatment for Bungarus multicinctus bite. Background mortality work (Gln GS (GS bite study snakebite Methods behavior rate injection analyzed Subsequently heatshock heat shock protein protein7 HSP , (HSP70) NFκB NF κB P65 P P53PUMA PPUMA P53 PUMA realtime real time Results symptoms Additionally GS, GDH (GDH GLS (GLS SLCA SLC A SLC7A1 tissues HO1 HO 1 HO- suppressed HSP7 Conclusion (HSP70 P6 P5 SLC7A (HSP7 (HSP

Abstract Angiotensin II (AngII) causes endothelial dysfunction. Eucommia ulmoides extract (EUE) is documented to manipulate AngII, but its impact on cardiac microvascular endothelial cell (CMVEC) function remains unknown. This study determines the effects of EUE on AngII-treated CMVECs. CMVECs were treated with different concentrations of AngII or EUE alone and/or the p53 protein activator, WR-1065, before AngII treatment, followed by examinations of the apoptotic, migratory, proliferative, and angiogenic capacities and nitric oxide (NO), p53, von Willebrand factor (vWF), endothelin (ET)-1, endothelial NO synthase (eNOS), manganese superoxide dismutase (MnSOD), hypoxia-inducible factor (HIF)-1α, and vascular endothelial growth factor (VEGF) levels. AngII induced CMVEC dysfunction in a concentration-dependent manner. EUE enhanced the proliferative, migratory, and angiogenic capacities and NO, MnSOD, and eNOS levels but repressed apoptosis and vWF and ET-1 levels in AngII-induced dysfunctional CMVECs. Moreover, AngII increased p53 mRNA levels, p-p53 levels in the nucleus, and p53 protein levels in the cytoplasm and diminishes HIF-1α and VEGF levels in CMVECs; however, these effects were counteracted by EUE treatment. Moreover, WR-1065 abrogated the mitigating effects of EUE on AngII-induced CMVEC dysfunction by activating p53 and decreasing HIF-1α and VEGF expression. In conclusion, EUE attenuates AngII-induced CMVEC dysfunction by upregulating HIF-1α and VEGF levels via p53 inactivation. (AngII (EUE (CMVEC unknown AngIItreated andor p p5 activator WR1065, WR1065 WR 1065, 1065 treatment apoptotic migratory proliferative , (NO) vWF, (vWF) ET1, ET1 ET 1, 1 (ET)-1 eNOS, (eNOS) MnSOD (MnSOD) hypoxiainducible hypoxia inducible HIF1α, HIF1α HIFα HIF 1α, 1α α (HIF)-1α (VEGF concentrationdependent concentration dependent manner ET- AngIIinduced Moreover pp53 pp p-p5 nucleus however WR-106 expression conclusion inactivation WR106 106 (NO (vWF (ET)- (eNOS (MnSOD pp5 p-p WR-10 WR10 10 (ET) WR-1 WR1 (ET WR-

ABSTRACT This study was conducted to examine the effect of feeding genetically modified organisms (GMO) compared with non - GMO diet on performance of layers in terms of egg production, egg broken rate and egg quality in laying hen. One hundred and ninety-two Hy-line brown laying hens were used in the feeding for four weeks. All the birds were randomly assigned into two dietary treatments groups, each with eight replicates (12 hens/ replicate). Significant difference was not found in egg production in layers fed GMO feed in diet compared with the non - GMO treatment. Whereas in terms of egg quality, a significant increase was observed in yolk color and eggshell thickness of layers fed GMO diet compared with layers fed non-GMO diet at 1st week. Additionally, there was a significant increase in eggshell thickness of layers fed GMO diet compared with layers fed non - GMO diet at 2nd, and 4th week. Layers fed GMO diet showed higher egg yolk value compared to the non-GMO diet in 1st week. However, no significant differences were found in other profiles such as egg quality including egg weight, albumen height, haugh units, shell color, and shell strength from 1st to 4th week since layers fed GMO. In conclusion, layers fed GMO diet showed significant improvement in eggshell thickness and yolk color and no significant difference was found in egg production. Layers fed GMO diets may enhance the egg quality, and further research need to be done. (GMO hen ninetytwo ninety Hyline Hy line weeks groups 12 (1 replicate. replicate . replicate) treatment nonGMO st Additionally 2nd nd th However weight height units conclusion done 1 (

ABSTRACT Introduction: Chylothorax after thoracic surgery is a severe complication with high morbidity and mortality rate of 0.10 (95% confidence interval [CI] 0.06 – 0.02). There is no agreement on whether nonoperative treatment or early reoperation should be the initial intervention. This systematic review and meta-analysis aimed to evaluate the outcomes of the conservative approach to treat chyle leakage after cardiothoracic surgeries. Methods: A systematic review was conducted in PubMed®, Embase, Cochrane Library Central, and LILACS (Biblioteca Virtual em Saúde) databases; a manual search of references was also done. The inclusion criteria were patients who underwent cardiothoracic surgery, patients who received any nonoperative treatment (e.g., total parenteral nutrition, low-fat diet, medium chain triglycerides), and studies that evaluated chylothorax resolution, length of hospital stay, postoperative complications, infection, morbidity, and mortality. Central Message Nonoperative treatment for chylothorax after cardiothoracic procedures has significant hospital stay, morbidity, mortality, and reoperation rates. Results: Twenty-two articles were selected. Pulmonary complications, infections, and arrhythmia were the most common complications after surgical procedures. The incidence of chylothorax in cardiothoracic surgery was 1.8% (95% CI 1.7 – 2%). The mean time of maintenance of the chest tube was 16.08 days (95% CI 12.54 – 19.63), and the length of hospital stay was 23.74 days (95% CI 16.08 – 31.42) in patients with chylothorax receiving nonoperative treatment. Among patients that received conservative treatment, the morbidity event was 0.40 (95% CI 0.23 – 0.59), and reoperation rate was 0.37 (95% CI 0.27 – 0.49). Mortality rate was 0.10 (95% CI 0.06 – 0.02). Conclusion: Nonoperative treatment for chylothorax after cardiothoracic procedures has significant hospital stay, morbidity, mortality, and reoperation rates. Introduction 010 0 10 0.1 95% 95 (95 [CI 006 06 0.0 0.02. 002 0.02 . 02 0.02) intervention metaanalysis meta analysis surgeries Methods PubMed PubMed® Embase Biblioteca Saúde databases done e.g., eg e g (e.g. nutrition lowfat low fat diet triglycerides, triglycerides , triglycerides) resolution infection rates Results Twentytwo Twenty two selected infections 18 1 8 1.8 17 7 1. 2%. 2 2% 2%) 1608 16 08 16.0 1254 12 54 12.5 19.63, 1963 19.63 19 63 19.63) 2374 23 74 23.7 31.42 3142 31 42 040 40 0.4 023 0.2 0.59, 059 0.59 59 0.59) 037 37 0.3 027 27 0.49. 049 0.49 49 0.49) Conclusion 01 0. 9 (9 00 e.g. (e.g 160 16. 125 5 12. 196 19.6 6 237 23. 31.4 314 3 4 04 05 0.5 03 ( e.g 19. 31.